EUVIMEDEUVIMED entdecken
Crossref

Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs

Simona Ferraro, Simona Lucchi, Chiara Montanari, Letizia Magnani, Martina Tosi, Davide Biganzoli, Andrea Lugotti, Laura Cappelletti, Alessia Poli, Elisa Pratiffi, Stephana Carelli, Laura Saielli und 5 weitere

Clinical Chemistry and Laboratory Medicine (CCLM) · 25.02.2025 · 63 (3) · 559-571

DOI: 10.1515/cclm-2024-0692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM), online erschienen am 03.10.2024. Verfasst von Simona Ferraro und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Vitamin B 12 Deficiency, Health Care Costs, Health Status. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The identification of vitamin B12 (B12) deficiency in the newborn may prevent neurological damage and a delay in the normal growth. In this study we characterized the incidence of B12 deficiency in newborns, the costs associated to the clinical diagnosis and management, and the relevance to optimize the use of cobalamin biomarkers during treatment follow-up.

Methods

Starting from a continuous case series of 146,470 screened newborns (November, 1st 2021- December, 3rd 2023), the Regional Reference Laboratory for Neonatal Screening identified 87 newborns having altered levels of biomarkers of cobalamin metabolism measured by newborn screening. These subjects were confirmed with a nutritional B12 deficiency of maternal origin by performing the serum B12 measurements and plasma homocysteine (Hcy) both on the newborns and respective mothers. A cost analysis was performed to characterize the costs/year of identifying and managing B12 deficiency cases.

Results

At baseline, median (interquartile range) serum B12 levels of 185.0 (142.3–246.0) ng/L and threefold increased plasma Hcy concentrations above the normal level confirmed a severe condition of deficiency in the newborns. After intramuscular B12 supplementation, serum B12 measured at the first follow up visit showed a fivefold increase, and the levels of Hcy returned to normal. From the healthcare perspective, the costs for diagnosing and managing all newborns with B12 deficiency is 188,480 €/year.

Conclusions

Preventing B12 depletion in newborns lowers healthcare costs and likely improves their health outcomes. Further studies are however required to address the clinical pathway to identify, treat and monitor pregnant women with marginal and low B12 status, in order to achieve these goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin B 12 DeficiencyHealth Care CostsHealth StatusHumansInfant, NewbornVitamin B 12FemaleNeonatal ScreeningMaleHomocysteineBiomarkers

Stichwörter der Autor:innen

costdeficiencyhealthcareimmunoassaysupplementationvitamin

Substanzen

Vitamin B 12HomocysteineBiomarkers

Autor:innen und Institutionen

  • Center of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, Milan, Italy.
  • Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
  • Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.
  • Department of Economics, Management, and Quantitative Methods, University of Milan, Milan, Italy.
  • Department of Health Sciences, University of Milan, Milan, Italy.
  • Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi", University of Milan, Milan, IItaly.

Zitieren

APA

Ferraro, S., Lucchi, S., Montanari, C., Magnani, L., Tosi, M., Biganzoli, D., Lugotti, A., Cappelletti, L., Poli, A., Pratiffi, E., Carelli, S., Saielli, L., Alberti, L., Zuccotti, G., Marsilio, M., Verduci, E., & Cereda, C. (2025). Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs. Clinical Chemistry and Laboratory Medicine (CCLM), 63(3), 559-571. https://doi.org/10.1515/cclm-2024-0692

Vancouver

Ferraro S, Lucchi S, Montanari C, Magnani L, Tosi M, Biganzoli D, et al. Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs. Clinical Chemistry and Laboratory Medicine (CCLM). 2025;63(3):559-571. doi:10.1515/cclm-2024-0692

BibTeX
@article{Ferraro2025,
  author = {Ferraro, Simona and Lucchi, Simona and Montanari, Chiara and Magnani, Letizia and Tosi, Martina and Biganzoli, Davide and Lugotti, Andrea and Cappelletti, Laura and Poli, Alessia and Pratiffi, Elisa and Carelli, Stephana and Saielli, Laura and Alberti, Luisella and Zuccotti, Gianvincenzo and Marsilio, Marta and Verduci, Elvira and Cereda, Cristina},
  title = {Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs},
  journal = {Clinical Chemistry and Laboratory Medicine (CCLM)},
  year = {2025},
  volume = {63},
  number = {3},
  pages = {559--571},
  doi = {10.1515/cclm-2024-0692}
}
Kostenlos starten →